Ethanol Promotes Mammary Tumor Growth and Angiogenesis: the Involvement of Chemoattractant Factor MCP-1
Overview
Authors
Affiliations
Alcohol consumption is a risk factor for breast cancer in humans. Experimental studies indicate that alcohol exposure promotes malignant progression of mammary tumors. However, the underlying cellular and molecular mechanisms remain unclear. Alcohol induces a pro-inflammatory response by modulating the expression of cytokines and chemokines. Monocyte chemoattractant protein-1 (MCP-1), also known as chemokine (C-C motif) ligand 2, is a pro-inflammatory chemokine implicated in breast cancer development/malignancy. We investigated the role of MCP-1 in alcohol-promoted mammary tumor progression. Using a xenograft model, we demonstrated that alcohol increased tumor angiogenesis and promoted growth/metastasis of breast cancer cells in C57BL/6 mice. Alcohol up-regulated the expression of MCP-1 and its receptor CCR2 in breast cancer cells in vitro and in vivo. Using a three-dimensional tumor/endothelial cell co-culture system, we demonstrated MCP-1 regulated tumor/endothelial cell interaction and promoted tumor angiogenesis. More importantly, MCP-1 mediated alcohol-promoted angiogenesis; an antagonist of the MCP-1 receptor CCR2 significantly inhibited alcohol-stimulated tumor angiogenesis. The CCR2 antagonist abolished ethanol-stimulated growth of mammary tumors in mice. We further demonstrated that MCP-1 enhanced the migration, but not the proliferation of endothelial cells as well as breast cancer cells. These results suggest that MCP-1 plays an important role in ethanol-stimulated tumor angiogenesis and tumor progression.
Zhang J, Hu D, Fang P, Qi M, Sun G EPMA J. 2025; 16(1):127-163.
PMID: 39991096 PMC: 11842682. DOI: 10.1007/s13167-024-00390-4.
Shen X, Zhang X, Li K, Huang G, Li X, Hou Y Heliyon. 2024; 10(16):e35793.
PMID: 39220957 PMC: 11363856. DOI: 10.1016/j.heliyon.2024.e35793.
Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice.
Li H, Xu M, Chen D, Wen W, Luo J Front Oncol. 2024; 14:1351839.
PMID: 38590657 PMC: 10999600. DOI: 10.3389/fonc.2024.1351839.
Cavallero S, Dekali S, Guitard N, Thery H, Helissey C, Francois S Front Cell Dev Biol. 2024; 11:1291016.
PMID: 38178868 PMC: 10764498. DOI: 10.3389/fcell.2023.1291016.
Metabolic dependencies of metastasis-initiating cells in female breast cancer.
Young C, Beziaud L, Dessen P, Madurga Alonso A, Santamaria-Martinez A, Huelsken J Nat Commun. 2023; 14(1):7076.
PMID: 37925484 PMC: 10625534. DOI: 10.1038/s41467-023-42748-8.